Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
1 competing product in clinical development for Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab Deruxtecan | Daiichi Sankyo | Phase 2 | Completed | 35 |